Atara Biotherapeutics ATRA Balance Sheet (2013-2026)

NASDAQ ATRA
$9.73 -0.18 (-1.87%)
As of: Sep 10, 2026 · 2:14 PM EDT
Reported Financials

Atara Biotherapeutics Quarterly Balance Sheet

Periods 52 quarters
Latest Jun 2026

Atara Biotherapeutics reported total assets of $21.02M and total liabilities of $58.02M for the quarter ended Jun 2026, down 43.0% year over year. This balance sheet covers 52 quarters of results from Sep 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
113.21M106.08M101.67M70.69M65.11M92.94M48.74M45.90M64.79M25.84M35.09M31.31M46.45M25.03M13.84M16.90M5.74M8.50M8.40M9.90M
Short-term InvestmentsInvestments (Current)
244.04M264.98M200.14M260.62M200.29M149.88M156.67M107.74M37.62M25.88M11.15M3.98M20.74M17.47M0.15M5.42M7.97M6.65M
Cash & Current Investments
357.25M371.07M301.81M331.31M265.40M242.82M205.41M153.64M102.41M51.73M46.24M35.29M67.19M42.50M13.99M22.32M13.71M8.50M8.40M16.55M
Receivables - NetNet Receivables
0.99M0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.33M1.48M8.88M1.91M1.25M0.32M
Receivables
0.99M0.67M0.64M0.25M40.22M0.40M0.51M0.16M34.11M35.83M2.42M1.33M1.48M8.88M1.91M1.25M0.32M
Raw Materials
1.21M1.32M2.75M2.42M2.33M4.36M3.64M1.65M0.96M
Work In Process
0.37M4.02M5.11M4.17M7.37M11.72M15.11M12.33M9.69M
Inventory
1.59M5.34M7.86M6.59M9.71M16.08M18.75M13.98M10.65M
Prepaid Assets
12.06M12.37M11.57M13.69M16.05M10.31M12.89M10.16M9.39M6.18M8.13M5.80M9.21M10.12M4.32M2.45M2.81M2.48M3.81M3.34M
Current Assets
369.50M384.62M314.39M346.98M283.05M295.08M224.18M172.32M118.70M101.87M106.43M62.41M91.86M64.89M27.18M24.77M18.43M12.21M12.17M13.53M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
53.48M53.78M9.11M8.33M7.27M6.30M5.85M5.35M4.63M3.86M2.99M2.32M1.66M1.29M0.28M0.18M0.15M0.07M0.06M0.04M
Other Non-Current Assets
1.40M2.37M51.43M7.23M7.17M7.02M6.91M6.58M6.29M4.84M3.87M3.61M3.36M3.10M2.84M0.93M0.88M0.89M0.89M0.77M
Non-Current Assets
80.43M83.51M82.89M89.14M85.27M81.34M77.90M74.12M70.09M63.63M58.84M54.87M50.85M44.20M34.86M12.13M11.73M8.02M7.82M7.49M
Assets
449.92M468.13M397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M20.23M20.00M21.02M
Liabilities
Current Liabilities
Accounts Payables
16.54M17.37M11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M0.13M0.64M0.82M
Payables
16.54M17.37M11.95M12.80M11.30M6.87M5.07M4.14M6.51M3.68M2.85M5.25M2.15M4.37M1.38M1.76M0.32M0.13M0.64M0.82M
Accumulated Expenses
19.14M25.15M16.38M16.32M17.61M17.66M8.91M12.56M14.43M19.01M18.20M11.19M8.06M6.59M9.50M4.78M2.55M1.80M1.75M2.15M
Other Accumulated Expenses
9.97M13.45M13.99M19.78M22.81M24.99M23.77M25.17M23.97M31.83M33.05M26.15M23.64M20.16M24.14M7.67M4.65M2.98M2.94M3.46M
Current Leases
2.58M12.81M11.78M12.10M12.41M11.26M13.09M13.02M13.65M12.88M12.85M2.24M1.95M1.03M1.01M1.10M
Current Taxes
Current Deferred Revenue
31.23M40.76M50.94M1.67M2.66M85.00M9.92M11.95M11.61M77.83M123.15M107.58M116.34M95.09M15.98M1.61M1.01M0.72M0.68M0.78M
Total Current Liabilities
86.15M105.79M101.56M65.69M72.24M78.92M67.88M74.55M79.09M142.23M180.69M148.27M155.98M134.57M47.89M14.56M18.06M14.92M5.64M6.85M
Non-Current Liabilities
Non-Current Deffered Revenue
26.84M55.71M45.00M43.33M42.34M77.00M78.04M75.56M73.93M37.56M0.72M0.57M0.47M
Preferred Stock Liabilities
Liabilities from Discontinued OperationsLiabilities from Discont. Ops
8.33M
Operating Leases
24.57M25.52M17.45M64.00M61.07M58.06M54.92M51.75M48.51M45.69M42.20M38.70M35.24M29.91M26.71M15.43M15.01M9.35M9.08M8.78M
Other Non-Current Liabilities
2.21M1.50M0.62M5.63M5.55M5.56M5.18M5.02M4.85M35.08M4.40M4.17M3.97M39.01M39.87M40.79M41.65M42.42M41.47M41.54M
Total Non-Current Liabilities
137.57M187.01M172.35M173.02M175.65M244.22M231.95M233.96M234.78M229.66M259.18M223.99M229.28M167.38M77.24M31.15M25.16M16.31M15.84M16.48M
Total Liabilities
139.78M188.51M172.96M178.64M181.20M249.78M237.12M238.99M239.63M264.74M263.58M228.15M233.25M206.38M117.11M71.94M66.80M58.74M57.31M58.02M
Shareholder's Equity
Common Equity
310.14M279.61M224.32M257.48M187.11M126.64M64.96M7.45M-50.84M99.23M-98.31M-110.87M-90.54M-97.28M500.00M-35.04M-36.63M-38.50M-37.31M-37.00M
Liabilities and Shareholders Equity
449.92M468.13M397.28M436.12M368.32M376.42M302.08M246.44M188.79M165.50M165.27M117.28M142.71M109.10M62.04M36.90M30.17M20.23M20.00M21.02M
Retained Earnings
-1371.37M-1464.72M-1552.83M-1534.36M-1618.45M-1693.02M-1767.80M-1838.90M-1908.70M-1969.15M-2000.90M-2019.95M-2041.86M-2054.55M-2016.54M-2014.16M-2018.46M-2021.87M-2026.01M-2030.84M
Treasury Shares